Xencor (XNCR) Net Equity Issued and Repurchased (2013 - 2018)

Xencor's (XNCR) quarterly Net Equity Issued and Repurchased came in at $260.2 million in Q1 2018, up 111.74% on a QoQ basis from $122.9 million in Q1 2015.

Xencor (XNCR) Net Equity Issued and Repurchased (2013 - 2018) Analysis & Trends

Xencor (XNCR) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $260.2 million in Q1 2018.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $260.2 million in Q1 2018; TTM through Dec 2018 was $260.2 million, a N/A change from a year earlier, with the FY2024 full-year figure at $201.3 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased for Q1 2018 stood at $260.2 million, up from $122.9 million in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for XNCR reached as high as $260.2 million in Q1 2018 and fell as low as $122.9 million in Q1 2015.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Xencor 1.47 Bn 1.09 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2018 260.25 Mn
Mar 31, 2018 260.25 Mn
Mar 31, 2015 122.91 Mn
Mar 31, 2015 122.91 Mn
Dec 31, 2013 70.52 Mn
Dec 31, 2013 70.52 Mn
Sep 30, 2013 2.40 Mn
Sep 30, 2013 2.40 Mn
Jun 30, 2013 10.00 Mn
Jun 30, 2013 10.00 Mn